Figure 3

Five-fold cross-validation for the cancer risk lncRNAs in six cancer datasets.
(A) Five-fold cross-validation for BLCA. (B) BRCA. (C) KICH. (D) KIRC. (E) LUAD. (F) PRAD. It is distinct that 23 cancer risk lncRNAs are robust and sensitive in distinguishing normal and tumor samples in six cancer datasets. FPR: False Positive Rate. TPR: True Positive Rate. AUC: Area Under the Curve.